The usefulness of flutemetamol for diagnostic imaging of neurogenerative disease

Not Applicable

Recruiting

• Conditions: Alzheimer's disease, Dementia with Lewy Bodies, Parkinson's syndrome, Frontotemporal lober degeneration, Parkinson's disease, Mild cognitive impairment, Non-Alzheimer's disease, Progressive aphasia, Neurodegenerative disease, Cerebral corticobasal degeneration, Progressive supranuclear palsy; Alzheimer's disease,Dementia with Lewy Bodies,Parkinson's syndrome,Frontotemporal lober degeneration

• Registration Number: JPRN-jRCTs051180214
• Lead Sponsor: Itoh Yoshiaki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-27
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Healthy control
1. Ages 20 and over
2. Written informed consent

Patient
1. Diagnosed as neurogenerative disease related to tau protain (Alzheimer's disease, Dementia with Lewy Bodies, Frontotemporal lobar degeneration, Parkinson's syndrome) by clinical symptom, Neurological findings, MRI and cognitive function test.
2. Written informed consent

Exclusion Criteria

Healthy control
1. A person who has brain disease (Parkinson's disease, dementia related disease, etc.)
2. A person who has serious disease complications or who has a history of these and who is considered as inappropriate by researcher.
3. Pregnant, unwilling to practice contraception during the study, or lactating female.
4. Participated in nuclear medicine examination within 6 months.
5. Claustrophobia
6. Judged inappropriate as subject by investigator.

Patient
1. A person who is complicated by brain disease other than the disease concerned (including an obvious history of cerebral infarction) and taking a drug that effects on the central nervous system
2. A person who has serious disease complications or has a history of these and is judged to be unsuitable as a subject of this research by a doctor who is a researcher etc.
3. Pregnant, unwilling to practice contraception during the study, or lactating female.
4. Participated in nuclear medicine examination within 6 months.
5. Claustrophobia
6. Judged inappropriate as subject by investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified